Table 3.
Salivary Flow Levels Before and After Treatment
| Group | No. of Patients | Salivary Flow | Median + IQR (Before Treatment) | Median + IQR (After Treatment | Levels Increased | Levels Did Not Change | Levels Decreased | Wilcoxon (z, p < 0.05) | % of Patients Noted Improvement |
|---|---|---|---|---|---|---|---|---|---|
| Vitamin B and Zinc Supplement Therapy | 48 | Unstimulated | 0.2 ± 0.19 | 0.21 ± 0.28 | 28 | 11 | 9 | −2.908 (0.04) | 58.33% |
| Stimulated | 0.8 ± 0.64 | 1 ± 0.53 | 31 | 8 | 9 | −3.705 (0.000) | 64.58% | ||
| Oral Capsaicin Rinse Therapy | 10 | Unstimulated | 0.14 ± 0.21 | 0.225 ± 0.41 | 7 | 1 | 2 | −1.955 (0.051) | 70% |
| Stimulated | 0.94 ± 0.85 | 0.91 ± 0.61 | 7 | 1 | 2 | −1.486 (0.137) | 70% |